What is the recommended enteral feeding dosage for a 75 kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Enteral Feeding Dosage for a 75 kg Patient

For a 75 kg patient requiring enteral nutrition, provide 1,000 mg/day of ribavirin-equivalent calories (approximately 1,500-2,000 kcal/day total energy) with 1.2-1.5 g/kg/day of protein (90-112.5 g/day), delivered via continuous pump feeding starting within 12-24 hours of admission. 1

Energy Requirements

  • Target 35-40 kcal/kg/day (2,625-3,000 kcal/day for a 75 kg patient) in postoperative or critically ill patients 1
  • For standard medical ICU patients, a minimum of 20 kcal/kg/day (1,500 kcal/day) should be achieved 2
  • Energy delivery should cover 1.3x Resting Energy Expenditure, with glucose providing 50-60% of non-protein energy and lipids providing the remainder 3

Protein Requirements

  • Deliver 1.2-1.5 g/kg/day of protein (90-112.5 g for a 75 kg patient) 1, 4
  • This protein target applies across cirrhosis, liver transplant, and general critical illness populations 1
  • In critically ill patients with obesity (BMI 30-40), consider up to 2 g/kg ideal body weight 1

Practical Implementation Protocol

Initiation Timeline

  • Start enteral nutrition within 12-24 hours of ICU admission or postoperatively 1
  • Do not delay for patients who cannot meet caloric requirements orally 1

Volume Progression

  • Increase feeding volume daily by 500 ml 2
  • Target maximum of 2,000 ml/day by day 4 of admission 2
  • This standardized protocol achieves an 86.2% delivery-to-prescription rate 2

Route Selection

  • Begin with gastric feeding via fine-bore nasogastric tube 5
  • Check gastric residual volume every 4 hours if gastrointestinal motility is questionable 6
  • If GRV exceeds 200 ml, review feeding policy and consider: 6
    • Reducing feeding rate
    • Adding prokinetic agents (metoclopramide or erythromycin)
    • Transitioning to post-pyloric (jejunal) feeding

Formula Selection

  • Use standard whole protein formulae as first-line 1
  • Consider concentrated high-energy formulae (>1.0 kcal/mL) in patients with ascites for fluid balance 1
  • Switch to BCAA-enriched formulae only if hepatic encephalopathy develops during feeding 1

Micronutrient Supplementation

Essential Daily Additions

  • Provide water-soluble vitamins and trace elements from day 1 of enteral nutrition 3
  • Administer thiamine 100-300 mg/day IV for 3-4 days in ICU patients, particularly those with suspected malnutrition or alcohol use, before starting glucose-containing feeds 1, 7
  • Standard enteral formulas at 1,500 kcal/day typically meet micronutrient needs, but patients receiving <1,500 kcal/day require additional supplementation 1

Monitoring Parameters

Clinical Assessment

  • Position patient at 30° or more during feeding and for 30 minutes afterward to minimize aspiration risk 6
  • Monitor for feeding intolerance signs: vomiting, abdominal distension, reflux into oral cavity 6
  • Check blood glucose regularly to detect hypoglycemia and avoid hyperglycemia 3

Laboratory Monitoring

  • Monitor phosphate, potassium, and magnesium levels to prevent refeeding syndrome, especially in malnourished patients 3
  • Routine vitamin level monitoring is not recommended except for vitamin D 7

Critical Pitfalls to Avoid

Refeeding Syndrome Prevention

  • In severely malnourished patients, start cautiously and monitor electrolytes closely 3
  • Never administer glucose before thiamine in at-risk patients, as this precipitates Wernicke's encephalopathy 3

Common Feeding Errors

  • Avoid interrupting feeds unnecessarily - EN interruptions occur in 32.1% of feeding days and significantly reduce caloric delivery 2
  • Do not use PEG placement in cirrhotic patients due to higher complication risk; use nasogastric or nasojejunal tubes instead 1
  • Enteral feeding can be safely administered even with esophageal varices present 1

Tolerance Issues

  • Post-pyloric feeding becomes necessary in approximately 36% of patients due to high gastric residuals 2
  • Delayed achievement of target feeding volume (>4 days) correlates with 73.3% mortality versus 26.1% in those reaching target by day 4 2

Alternative Approach: Permissive Underfeeding

  • In select mechanically ventilated patients, permissive underfeeding (50% of daily energy expenditure, approximately 1,300-1,500 kcal/day for 75 kg patient) with maintained protein at 1.2-1.5 g/kg/day produces similar outcomes to full feeding 8
  • This approach reduces insulin requirements and improves gastrointestinal tolerance 8
  • However, standard full feeding remains the primary recommendation unless specific contraindications exist 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

IV Infusion of D50 for Malnutrition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intensive medicine - Guidelines on Parenteral Nutrition, Chapter 14.

German medical science : GMS e-journal, 2009

Research

Nutrition in the critically ill patient: part III. Enteral nutrition.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2003

Guideline

Gastric Residual Volume Threshold for Enteral Feeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IV Multivitamin Efficacy in Parenteral Nutrition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What parenteral nutrition should be given to a patient after an exploratory laparotomy (exlap) due to perforated peptic ulcer disease?
What is the most appropriate daily protein intake for an 81-year-old female critically ill patient with status epilepticus, normal kidney and liver function, weighing 60 kg?
How should I prescribe nutrition through a nasogastric (NG) tube?
What are the estimated calorie requirements for a 38kg patient through a nasogastric (NG) tube?
How to distribute 1300 kilocalories (kcal) and 50 grams (g) of protein across 6 divided feedings?
What are the indications for prescribing compression stockings to a patient with a history of cardiovascular disease, diabetes, or previous DVT?
What is the recommended pneumococcal vaccine (Pneumococcal Conjugate Vaccine (PCV) or Pneumococcal Polysaccharide Vaccine (PPSV)) schedule for adults aged 65 and older or those with chronic medical conditions, such as chronic heart disease, lung disease, or impaired immune system?
How to manage orthostatic dizziness in a patient with a history of cardiovascular disease, diabetes, or previous DVT?
What is the best management approach for a young adult patient with thalassemia major (a genetic disorder affecting hemoglobin production) and known hypothyroidism (underactive thyroid), presenting with impaired renal function (elevated creatinine and urine protein-to-creatinine ratio), anemia (low hemoglobin), and currently on interval blood transfusions?
What is the recommended treatment for a patient with papillary thyroid cancer (PTC) that involves the mediastinum?
What is the definition, epidemiology, etiology, pathophysiology, clinical presentation, laboratory findings, and imaging characteristics of intussusception and internal intestinal hernias?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.